“…RAD52 is a homologous recombination (HR) protein that is conserved from bacteriophage to humans. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…[PURPOSE]: The purpose of this study was to develop a regression model to estimate the heart rate at the lactate threshold (HR(LT)) and the heart rate at the ventilatory threshold (HR(VT)) using the heart rate threshold (HRT), and to test the validity of the regression model. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The aim of this study was to determine the relative validity of a single 24-h dietary recall (24HR) in measuring the intake of five nutrients in a cohort of Australian toddlers compared to a combined 24HR and 2-day estimated food record (2DFR). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A tight coupling between the neuronal activity and the cerebral blood flow (CBF) is the motivation of many hemodynamic response (HR)-based neuroimaging modalities. The increase in neuronal activity causes the increase in CBF that is indirectly measured by HR modalities. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Homologous recombination (HR) enables the exchange of genetic material between and within species. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Ten male Japanese amateur cyclists performed cycling individually for at least 2 consecutive hours. HR was measured using an HR monitor during the race, and we estimated the energy expenditure (EE) during the race using the HR–VO(2) relationship in advance. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients with HR gene mutations exhibit atrichia, and in rare cases, immunodeficiency. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Conversely, among women, rates in blacks were 21% lower for HR+/HER2- and comparable for HR+/HER2+ but 29% and 93% higher for HR-/HER2+ and triple-negative subtypes, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…4-Hexyl resorcinol (4HR) is an organic compound and has been used in skin care application. 4HR is an M2-type macrophage activator and elevates vascular endothelial growth factor (VEGF) expression via the hypoxia-inducible factor (HIF)-independent pathway. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Colistin-heteroresistant (CST-HR) Enterobacterales isolates have been identified recently, challenging the clinical laboratories since routine susceptibility tests fail to detect this phenotype. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Univariate logistic regression revealed that serum concentrations for the median CA125 correlated with DFS (HR = 1.76, p = 0.033) and OS (HR = 1.42, p = 0.025), while the median of HE4 marker correlated with DFS (HR = 1.96, p = 0.015) and OS (HR = 1.83, p = 0.004). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this study, we tested the efficiency of hairy root (HR) induction in C. asiatica from leaf and petiole explants. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Overall, the addition of CDK4/6 inhibitors to ET was associated with a statistically significant benefit to OS (HR, 1.33; 95% CI, 1.19-1.48; P < .001). Compared with ET alone, treatment with CDK4/6 inhibitors plus ET was associated with improved OS for the following subgroups: first-line therapy (HR, 1.35; 95% CI, 1.18-1.54; P < .001), second-line therapy (HR, 1.30; 95% CI, 1.09-1.54; P < .001), premenopausal women (HR, 1.32; 95% CI, 1.04-1.66; P < .001), postmenopausal women (HR, 1.34; 95% CI, 1.18-1.52; P < .001), visceral metastasis (HR, 1.31; 95% CI, 1.12-1.53; P < .001), bone-only metastasis (HR, 1.22; 95% CI, 0.88-1.68; P < .001), age younger than 65 years (HR, 1.25; 95% CI, 1.06-1.49; P < .001), and age 65 years or older (HR, 1.38; 95% CI, 1.11-1.72; P < .001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: A high resting heart rate (HR) has been associated with an increased risk of diabetes mellitus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Compared to transvenous-VVI patients, leadless-VVI patients in four subgroups [malignancy, HR 0.68 (0.48–0.95); diabetes, HR 0.69 (0.53–0.89); TVD, HR 0.60 (0.44–0.82); COPD, HR 0.73 (0.55–0.98)] had fewer complications, in three subgroups [diabetes, HR 0.58 (0.37–0.89); TVD, HR 0.46 (0.28–0.76); COPD, HR 0.51 (0.29–0.90)) had fewer reinterventions, and in four subgroups (malignancy, HR 0.52 (0.32–0.83); diabetes, HR 0.52 (0.35–0.77); TVD, HR 0.44 (0.28–0.70); COPD, HR 0.55 (0.34–0.89)] had lower rates of the combined outcome. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In the SSG group, although no significant differences were found in HR responses, %HR(max) was below 90% in week 1 and week 2. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Risks for incident BV were presentation ≤14 days since onset of menses (hazard ratio (HR) 2.3 (95% CI, 1.2–4.7), report of new sex partner with BV history (HR 3.63 (1.1–11.9)), change in vaginal discharge (HR 2.6 (1.3–5.2)) and detection of any of several BVAB in vaginal fluid at enrollment, including BVAB1 (HR 6.3 (1.4–28.1)), BVAB2 (HR 18.2 (6.4–51.8)), BVAB3 (HR 12.6 (2.7–58.4)), G. vaginalis (HR 3.9 (1.5–10.4)), Atopobium vaginae (HR 4.2 (1.9–9.3)), Leptotrichia spp (9.3 (3.0–24.4)), and Megasphaera-1 (HR 11.5 (5.0–26.6)). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In women, hazard ratios for the 5th quintile were associated with decreasing risk of total cancer (HR = 0.86, 95%CI: 0.79, 0.93) and for cancers of the gallbladder (HR = 0.23, 95%CI: 0.08, 0.62), breast (HR = 0.70, 95%CI: 0.61, 0.81), melanoma of skin (HR = 0.61, 95%CI: 0.42, 0.88), and cancers of the lymph−/hematopoietic tissue (HR = 0.61, 95%CI: 0.44, 0.83). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Furthermore, haplotype AASA remained a negative prognostic factor for premenopausal patients receiving adjuvant chemotherapy in terms of DDFS (aHR, 4.5; P = 0.0005), DFS (HR, 3.2; P = 0.003), and OS (HR, 6.4; P = 0.0009). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In univariate analyses, histology [hazard ratio (HR), 1.94; 95% confidence interval (CI), 1.18–3.49; P=0.0082], pT (HR, 2.34; 95% CI, 1.55–3.62; P<0.0001), pN (HR, 2.85; 95% CI, 1.81–4.69; P<0.0001), lymphatic invasion (HR, 2.08; 95% CI, 1.26–3.70; P=0.0036), venous invasion (HR, 1.79; 95% CI, 1.21–2.64; P=0.0039), neoadjuvant chemotherapy (NAC) (HR, 2.01; 95% CI, 1.35–3.00; P=0.0005) and IMP3 expression (HR, 2.12; 95% CI, 1.40–3.29; P=0.0003) were significantly associated with overall survival. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso